When exploring the landscape of peptide synthesis and specialized manufacturing, the PolyPeptide Group stands out as a significant entity. As an enthusiast who has followed the evolution of this field, I have often looked into the operational structure of major industry players. A common question that arises for those researching this sector is, "Where is the polypeptide group headquarters?"
The Central Hub: PolyPeptide Group AG
The core of the organization is located in Switzerland. Specifically, the headquarters in 24 Neuhofstrasse Baar, Zug Switzerland (Zip: 6340 Baar, Switzerland) serves as the primary base for the PolyPeptide Group. It is important to distinguish this from other industry entities, such as the organization with headquarters in Bubendorf, Switzerland, which is a separate entity.
For those looking for official contact points, the Headquarters at Neuhofstrasse 24, Baar, Zug, 6340, Switzerland is the central administrative node. Whi PolyPeptide Group: Grow with us le many associate the brand with its long history dating back to 1952 in Malmö, Sweden, the current corporate structure reflects a globalized CDMO (Contract Development & Manufacturing Organization).
G PolyPeptide Labs is a world leader in the manufacture of polypeptide, custom peptide Synthesis, peptide synthesis and generic peptide : generic GMP peptide lobal Operational Network
The company’s reach extends far beyond its Swiss roots. As a specialized Contract Development & Manufacturing Organization, they maintain a robust network of facil PolyPeptide is a focused Contract Development & Manufacturing Organization (CDMO) for peptide- and oligonucleotide-based active pharmaceutical ingredients. ities. Their operation PolyPeptide Group is a focused Contract Development & Manufacturing Organization (CDMO) for peptide- and oligonucleotide-based active pharmaceutical al footprint includes:
* Europe: Beyond the Swiss base, they operate in Braine-l'Alleud, Belgium, as well as sites in Strasbourg, France, and their historical roots in Malmö, Sweden.
* United States: The PolyPeptide presence in the US is substantial. Key locations include 365 Maple Ave, Torrance, Dating back to 1952, PolyPeptide today runs a global network of six cGMP-certified facilities in Europe, the U.S. and India. PolyPeptide Group AG's shares (SIX: CA 90503 and the 9395 Cabot Drive, San Diego, CA, 92126 facility. For those trying to reach their US offices, the Offi PolyPeptide Group ce: 858-455-0300 line is a frequently referenced contact point.
* India: A major part of their growth strategy involves the Ambernath, India facility. Located at Plot No K 28, Near Additional MIDC, Anand Nagar, Ambernath (East), this site has seen significant investment to expand its Ambernath facility in India, highlighting their commitment to global supply chains.
Industry Context and Evolution
The PolyPeptide brand is synonymous with high-quality, GMP-grade production. Whether discussing peptide synthesis or the manufacturing of complex active ingredients, the company is a focused Contract Development & Manufacturing Organization that has navigated the industry since 1952.
From my perspective as someone tracking these developments, the shift toward a more integrated global model—incorporating sites from Torrance, San Diego, Braine-l'Alleud, Malmö, Ambernath, and Strasbourg—demonstrates a clear focus on scale and technical expertise. They have successfully transitioned from local manufacturing roots to a publicly traded entity on the SIX Swiss Exchange (PPGN).
Summary of Key Information
For researchers and industry followers, tracking the PolyPeptide Group requires keeping an eye on t Locations · Neuhofstrasse 24. Baar, CH · Limhamnsvägen 108. Malmö, Skåne 20061, SE · 365 Maple Ave. Torrance, CA 90503, US · Chaussee De Tubize 297. heir regulatory and physical hubs. While some older records might point to 19 Dammstrasse, Zug, 6300, CH, the current primary registration remains at the Neuhofstrasse address.
Understanding this organizational structure helps in appreciating how PolyPeptide's capabilities are distributed across four continents. By maintaining a network that spans from K-28, Additional MIDC Area, Ambernath (East) to the Torrance and San Diego sites, they continue to solidify their position in the specialized market of peptide manufacturing. Whether you are reviewing their history or their latest facility upgrades, it is clear that the PolyPeptide Group remains a cornerstone of the global manufacturing landscape.